Shuan Rao

11.3k total citations · 2 hit papers
50 papers, 3.9k citations indexed

About

Shuan Rao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuan Rao has authored 50 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuan Rao's work include Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Muscle metabolism and nutrition (5 papers). Shuan Rao is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Muscle metabolism and nutrition (5 papers). Shuan Rao collaborates with scholars based in China, United States and United Kingdom. Shuan Rao's co-authors include Chengyu Jiang, Josef Penninger, Feng Guo, Keiji Kuba, Yumiko Imai, Xiaozhong Peng, Yi Huan, Michael A. Crackower, Renu Sarao and Teiji Wada and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

Shuan Rao

47 papers receiving 3.9k citations

Hit Papers

Angiotensin-converting enzyme 2 protects from severe acut... 2005 2026 2012 2019 2005 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Angiotensin-converting enzyme 2 protects from severe acute lung failure
    2005 1.8k citations Shuan Rao, Chengyu Jiang et al. profile →
  2. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
    2020 530 citations Tao Liu, Qinglv Wei et al. Nucleic Acids Research profile →

Peers

Shuan Rao
Jie Xiong China
Zhichao Chen China
Guanmin Jiang China
Bin Sun China
Chunling Zhao China
Huan Li China
Daniel Sedding Germany
Juanjuan Xu China
Yi Zeng China
Jie Xiong China
Shuan Rao
Citations per year, relative to Shuan Rao Shuan Rao (= 1×) peers Jie Xiong

Countries citing papers authored by Shuan Rao

Since Specialization
Citations

This map shows the geographic impact of Shuan Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuan Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuan Rao more than expected).

Fields of papers citing papers by Shuan Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuan Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuan Rao. The network helps show where Shuan Rao may publish in the future.

Co-authorship network of co-authors of Shuan Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Shuan Rao. A scholar is included among the top collaborators of Shuan Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuan Rao. Shuan Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhuoying, Yingying Liu, Yun Liang, et al.. (2025). Jaceosidin overcomes osimertinib resistance in lung cancer by inducing G2/M cycle arrest through targeting DDB1. Toxicology and Applied Pharmacology. 499. 117327–117327. 1 indexed citations
2.
Li, Lian, Yuchen Liu, Shanshan Zhao, et al.. (2025). Human Pluripotent Stem Cell-Derived Alveolar Organoids for Gene-editing and Lung Adenocarcinomas Modeling. International Journal of Biological Sciences. 21(14). 6285–6304.
3.
4.
Guo, Quanwei, Weijun Yu, Jianhua Zhang, et al.. (2024). Remodelin delays non‐small cell lung cancer progression by inhibiting NAT10 via the EMT pathway. Cancer Medicine. 13(11). e7283–e7283. 8 indexed citations
5.
6.
Xu, Xi, Yanhui Yu, Wendy Zhang, et al.. (2024). SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming. Nature Cell Biology. 26(3). 464–477. 25 indexed citations
7.
O’Cathail, Séan M., Meng Qiao, Richard Adams, et al.. (2023). A Phase 1 Trial of the Safety, Tolerability, and Biological Effects of Intravenous Enadenotucirev (EnAd), a Novel Oncolytic Virus, in Combination with Chemoradiotherapy in Locally Advanced Rectal Cancer (CEDAR). International Journal of Radiation Oncology*Biology*Physics. 117(2). e329–e330. 1 indexed citations
8.
Cronin, Shane J. F., Shuan Rao, Miguel Á. Tejada, et al.. (2022). Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer. Science Translational Medicine. 14(660). eabj1531–eabj1531. 21 indexed citations
9.
Zhang, Zheng, et al.. (2022). Effect of aerobic exercise on lung regeneration and inflammation in mice. Immunobiology. 227(6). 152296–152296. 2 indexed citations
10.
Yang, Jianjun, Hua Wu, Xiaoying Dong, et al.. (2021). Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer. Translational Lung Cancer Research. 10(2). 926–935. 8 indexed citations
11.
Liu, Tao, Qinglv Wei, Jing Jin, et al.. (2020). The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Research. 48(7). 3816–3831. 530 indexed citations breakdown →
12.
Yang, Jianjun, et al.. (2020). Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade. Frontiers in Oncology. 10. 1727–1727. 119 indexed citations
13.
Jin, Jing, Nina Xue, Yuan Liu, et al.. (2019). A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models. Acta Pharmaceutica Sinica B. 10(2). 276–288. 28 indexed citations
14.
Fontana, Elisa, Chanthirika Ragulan, David Cunningham, et al.. (2017). Multiplatform assay to classify formalin-fixed paraffin-embedded (FFPE) colorectal cancer (CRC) samples into molecular subtypes with mutational profiles. Annals of Oncology. 28. v194–v194. 1 indexed citations
15.
Rao, Shuan, Shane J. F. Cronin, Verena Sigl, & Josef Penninger. (2017). RANKL and RANK: From Mammalian Physiology to Cancer Treatment. Trends in Cell Biology. 28(3). 213–223. 65 indexed citations
16.
Rao, Shuan, Heng Yang, Josef Penninger, & Guido Kroemer. (2014). Autophagy in non-small cell lung carcinogenesis. Autophagy. 10(3). 529–531. 53 indexed citations
17.
Wang, Hongliang, Shuan Rao, & Chengyu Jiang. (2006). Molecular pathogenesis of severe acute respiratory syndrome. Microbes and Infection. 9(1). 119–126. 11 indexed citations
18.
Rao, Shuan, et al.. (2001). External Beam Radiotherapy and Intraluminal Brachytherapy in Advanced Inoperable Esophageal Cancer. American Journal of Clinical Oncology. 24(2). 128–130. 8 indexed citations
19.
Ford, Hugo, David Cunningham, Paul J. Ross, et al.. (2000). Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma. British Journal of Cancer. 83(2). 146–152. 21 indexed citations
20.
Taylor, Anne, et al.. (1974). Human skeletal muscle debranching enzyme activities with exercise and training. European Journal of Applied Physiology. 33(4). 327–330. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Xiong Breakdown of academic impact, for papers by Zhichao Chen Breakdown of academic impact, for papers by Guanmin Jiang Breakdown of academic impact, for papers by Bin Sun Breakdown of academic impact, for papers by Chunling Zhao Breakdown of academic impact, for papers by Huan Li Breakdown of academic impact, for papers by Daniel Sedding Breakdown of academic impact, for papers by Juanjuan Xu Breakdown of academic impact, for papers by Yi Zeng
Rankless by CCL
2026